Skip to main content

Medikamente zur Behandlung von sexuellen Funktions störungen

  • Chapter
Kompendium der Psychiatrischen Pharmakotherapie
  • 4944 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Atlantis E, Sullivan T (2012) Bidirectional association between depression and sexual dysfunction: a systematic review and meta-analysis. J Sex Med 9(6):1497–1507

    Article  PubMed  Google Scholar 

  • Erdmann E (2012) Sicherheit von β-Blockern: Vorurteile und Realität. Internist (Berl) 53: 630–634

    Article  CAS  Google Scholar 

  • Gacci M, Corona G, Salvi M et al (2012) A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 61: 994–1003

    Article  CAS  PubMed  Google Scholar 

  • La Torre A, Conca A, Duffy D et al (2013) Sexual dysfunction related to psychotropic drugs: a critical review. Part II: antipsychotics. Pharmacopsychiatry 46(6): 201–208

    Google Scholar 

  • La Torre A, Giupponi G, Duffy DM et al (2014) Sexual dysfunction related to psychotropic drugs: a critical review. Part III: Mood stabilizers and anxiolytic drugs. Pharmacopsychiatry 47(1): 1–6

    Google Scholar 

  • Malik P, Kemmler G, Hummer M et al; and the EUFEST Study Group (2011) Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial. J Clin Psychopharmacol 31: 274–280

    Google Scholar 

  • McMahon CG, Jannini E, Waldinger M et al (2013) Standard operating procedures in the disorders of orgasm and ejaculation. J Sex Med 10(1):204–229

    Article  PubMed  Google Scholar 

  • Müller MJ (2011) Sexuelle Funktionsstörungen - Wenn Psychopharmaka das Liebesleben lähmen. NeuroTransmitter 2:52–59

    Google Scholar 

  • Nastri CO, Lara LA, Ferriani RA et al (2013) Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev 6: CD009672

    Google Scholar 

  • Porst H, Burnett A, Brock G et al (2013) SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med 10:130–171

    Article  CAS  PubMed  Google Scholar 

  • Schmidt HM, Hagen M, Kriston L et al (2012) Management of sexual dysfunction due to antipsychotic drug therapy. Cochrane Database Syst Rev 11:CD003546

    Google Scholar 

  • Vigen R, O’Donnell CI, Barón AE et al (2013) Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 310(17):1829–1836

    Article  CAS  PubMed  Google Scholar 

  • Yee A, Loh HS, Hisham Hashim HM et al (2014) The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a metaanalysis study. J Sex Med 11(1):22–32

    Article  CAS  PubMed  Google Scholar 

  • Yuan J, Zhang R, Yang Z et al (2013) Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol 63:902–912

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Benkert, O. (2015). Medikamente zur Behandlung von sexuellen Funktions störungen. In: Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54769-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54769-0_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54768-3

  • Online ISBN: 978-3-642-54769-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics